Non-annotated gene. Preliminary data : if you are an author who wish to write a full paper/card on this gene, contribute in submission tool
Other Information
Locus ID:
NCBI: 6751
MIM: 182451
HGNC: 11330
Ensembl: ENSG00000139874
Variants:
dbSNP: 6751
ClinVar: 6751
TCGA: ENSG00000139874
COSMIC: SSTR1
RNA/Proteins
| Gene ID | Transcript ID | Uniprot |
|---|---|---|
| ENSG00000139874 | ENST00000267377 | P30872 |
Expression (GTEx)
Pathways
Protein levels (Protein atlas)
References
| Pubmed ID | Year | Title | Citations |
|---|---|---|---|
| 33491286 | 2021 | Predictive and prognostic significance of tumour subtype, SSTR1-5 and e-cadherin expression in a well-defined cohort of patients with acromegaly. | 6 |
| 33675866 | 2021 | The impact of SST2 trafficking and signaling in the treatment of pancreatic neuroendocrine tumors. | 3 |
| 35014332 | 2021 | Selectivity Comparison of Tumor-Imaging Probes Designed Based on Various Tumor-Targeting Strategies: A Proof of Concept Study. | 1 |
| 33491286 | 2021 | Predictive and prognostic significance of tumour subtype, SSTR1-5 and e-cadherin expression in a well-defined cohort of patients with acromegaly. | 6 |
| 33675866 | 2021 | The impact of SST2 trafficking and signaling in the treatment of pancreatic neuroendocrine tumors. | 3 |
| 35014332 | 2021 | Selectivity Comparison of Tumor-Imaging Probes Designed Based on Various Tumor-Targeting Strategies: A Proof of Concept Study. | 1 |
| 29282035 | 2017 | Somatostatin and CXCR4 chemokine receptor expression in hepatocellular and cholangiocellular carcinomas: tumor capillaries as promising targets. | 21 |
| 29282035 | 2017 | Somatostatin and CXCR4 chemokine receptor expression in hepatocellular and cholangiocellular carcinomas: tumor capillaries as promising targets. | 21 |
| 26474434 | 2016 | Prognostic Value of Somatostatin Receptor Subtypes in Pancreatic Neuroendocrine Tumors. | 12 |
| 26474434 | 2016 | Prognostic Value of Somatostatin Receptor Subtypes in Pancreatic Neuroendocrine Tumors. | 12 |
| 25734919 | 2015 | Aberrant methylation inactivates somatostatin and somatostatin receptor type 1 in head and neck squamous cell carcinoma. | 17 |
| 25962406 | 2015 | An immunohistochemical investigation of the expression of somatostatin receptor subtypes - should therapeutic trials be performed to determine the efficacy of somatostatin analogs in treating advanced thyroid malignances? | 4 |
| 25734919 | 2015 | Aberrant methylation inactivates somatostatin and somatostatin receptor type 1 in head and neck squamous cell carcinoma. | 17 |
| 25962406 | 2015 | An immunohistochemical investigation of the expression of somatostatin receptor subtypes - should therapeutic trials be performed to determine the efficacy of somatostatin analogs in treating advanced thyroid malignances? | 4 |
| 24512486 | 2014 | Does somatostatin have a role in the regulation of cortisol secretion in primary pigmented nodular adrenocortical disease (ppnad)? a clinical and in vitro investigation. | 3 |
Citation
Dessen P
SSTR1 (somatostatin receptor 1)
Atlas Genet Cytogenet Oncol Haematol. 2003-02-01
Online version: http://atlasgeneticsoncology.org/gene/42401/sstr1
